Intravenous Dexmedetomidine-Ketamine Versus Ketamine-Propofol for Procedural Sedation in Adults Undergoing Short Surgical Procedures: A Randomized Controlled Trial.
dexmedetomidine
ketamine
procedural interference
propofol
rescue bolus
sedation
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
20
06
2023
medline:
24
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
Background and objective Moderate to deep sedation is a prerequisite during total intravenous anesthesia for short-duration surgeries, and it can be achieved by using individual drugs or in combination. Our study compared dexmedetomidine-ketamine (DK) versus ketamine-propofol (KP) in terms of sedation, procedural interference, hemodynamics, and incidence of side effects in patients undergoing short surgical procedures. Methods A total of 194 patients scheduled for short-duration elective surgeries were randomly allocated into two groups. Group DK received a loading dose of 1 µg/kg of dexmedetomidine and 1 mg/kg of ketamine followed by a maintenance infusion of dexmedetomidine at 0.3 µg/kg/h. Group KP received a loading dose of 1 mg/kg of ketamine and 1 mg/kg of propofol followed by a maintenance infusion of propofol at 25 µg/kg/h. For procedural interference, a rescue ketamine bolus was administered at 0.25 mg/kg. Patients were monitored for the requirement of rescue ketamine bolus, procedural interference, hemodynamics, sedation, recovery time, and adverse effects. Results The procedural interference was higher in group KP than in group DK and the difference was statistically significant (P=0.001). The time to the first rescue bolus was 8.72 ± 4.47 minutes in group KP and 10.82 ± 4.01 minutes in group DK, with a difference of 2.1 minutes (p
Identifiants
pubmed: 37485154
doi: 10.7759/cureus.40676
pmc: PMC10357391
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e40676Informations de copyright
Copyright © 2023, Kakarla et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Braz J Anesthesiol. 2020 Nov-Dec;70(6):620-626
pubmed: 33293038
J Cardiothorac Vasc Anesth. 2006 Aug;20(4):515-9
pubmed: 16884981
Medicine (Baltimore). 2020 Oct 23;99(43):e22712
pubmed: 33120766
Am J Emerg Med. 2008 Nov;26(9):985-1028
pubmed: 19091264
J Clin Pharm Ther. 2019 Apr;44(2):312-317
pubmed: 30635940
J Emerg Med. 2022 Aug;63(2):283-289
pubmed: 35550843
Acad Emerg Med. 2011 Mar;18(3):237-45
pubmed: 21401785
Anaesthesia. 2010 Mar;65(3):254-9
pubmed: 20105150
Anesth Analg. 2000 Apr;90(4):858-62
pubmed: 10735789
Anesthesiology. 2019 Jul;131(1):164-185
pubmed: 30920966
Clin Ther. 2010 Apr;32(4):701-9
pubmed: 20435239
J Burn Care Res. 2012 Nov-Dec;33(6):718-22
pubmed: 22878491
Crit Care Nurse. 2005 Feb;25(1):14-5
pubmed: 15756730
Neuropharmacology. 1991 Oct;30(10):1065-71
pubmed: 1684646
Expert Opin Drug Metab Toxicol. 2008 May;4(5):619-27
pubmed: 18484919
Br Med J. 1974 Jun 22;2(5920):656-9
pubmed: 4835444
Ann Card Anaesth. 2018 Apr-Jun;21(2):143-150
pubmed: 29652275
Br J Anaesth. 2015 Apr;114(4):663-8
pubmed: 25500679
Ann Card Anaesth. 2017 Oct-Dec;20(4):422-426
pubmed: 28994677
Anesthesiology. 1982 Feb;56(2):119-36
pubmed: 6892475
Anesthesiology. 2000 Aug;93(2):382-94
pubmed: 10910487
Korean J Anesthesiol. 2017 Aug;70(4):398-406
pubmed: 28794834
J Clin Anesth. 1995 Feb;7(1):89-91
pubmed: 7772368
Gastrointest Endosc. 2016 May;83(5):928-33
pubmed: 26364968
J Pak Med Assoc. 2017 May;67(5):693-697
pubmed: 28507353
Ann Card Anaesth. 2017 Apr-Jun;20(2):182-187
pubmed: 28393778
Eur Rev Med Pharmacol Sci. 2016 Apr;20(8):1490-4
pubmed: 27160119